15th Jun 2020 11:10
Creo Medical Group PLC - Chepstow, Wales-based medical devices - Gets CE marking on five new devices which form the Creo gastro-intestinal suite of advanced energy devices across four technology platforms. The CE marking of the full range of products provides EU and UK clearance ahead of their commercial launch. The newly CE marked products include Speedboat Slim, SpydrBlade Flex, MicroBlate Fine, MicroBlate Flex and SlypSeal Flex. Creo expects to introduce the devices into clinical practice and prepare for commercialisation in the second half of 2020.
Current stock price: 199.80 pence
Year-to-date change: up 10%
By Tapan Panchal; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Creo Medical